» Articles » PMID: 39868600

Postprandial Time in Tight Range with Faster Insulin Aspart Compared with Standard Insulin Aspart in Youth with Type 1 Diabetes Using Automated Insulin Delivery

Abstract

Aims: The aim of this study was to assess postprandial glycaemic outcomes using automated insulin delivery with faster acting insulin aspart (FIA) or standard insulin aspart (SIA) over 4 weeks in youth (aged 10-18 years) with type 1 diabetes.

Materials And Methods: We undertook a secondary analysis of postprandial glycaemic outcomes from a double-blind, randomised, crossover study comparing FIA to SIA using an investigational version of MiniMed™ 780G. Endpoints included postprandial time in tight range (70-140 mg/dL; TITR), postprandial glucose excursions and peak glucose, and incremental area under curve (iAUC).

Results: The mean ± SD age of 30 included participants was 15.0 ± 1.7 years, 47% were male, mean HbA1c was 7.5% ± 0.9% (58 ± 9.8 mmol/mol) and the number of meals per day per participant was 3.2 ± 1.2 meals. Overall, the postprandial outcomes were improved with FIA compared with SIA. Mean glucose at the start of the meal was 151 mg/dL in the FIA group and reached a peak glucose of 194 mg/dL, compared with starting level of 151 mg/dL in the SIA group and a peak of 198 mg/dL (difference in excursion: -3.8 mg/dL; 95% confidence interval -5.8 to -1.7; p <0.001). FIA group also had a 1.9% increase in mean TITR (p = 0.02) and a 2.0-mg/dL decrease in mean iAUC (p = 0.003). Differences in outcomes were the most noticeable for breakfast, meals with a larger amount of carbohydrates (>45 g) and participants with lower insulin-to-carbohydrate ratios.

Conclusions: Faster insulin formulation with AID improved postprandial glycaemic outcomes and could be a useful therapeutical option in youth with type 1 diabetes that have challenges achieving glycaemic targets.

Citing Articles

Postprandial time in tight range with faster insulin aspart compared with standard insulin aspart in youth with type 1 diabetes using automated insulin delivery.

Dovc K, Spanbauer C, Chiarle E, Bratina N, Frohlich-Reiterer E, Potocnik N Diabetes Obes Metab. 2025; 27(4):2147-2153.

PMID: 39868600 PMC: 11885092. DOI: 10.1111/dom.16211.

References
1.
Cohen E, Tsoukas M, Legault L, Vallis M, Von Oettingen J, Palisaitis E . Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, Canada. Lancet Digit Health. 2024; 6(7):e489-e499. DOI: 10.1016/S2589-7500(24)00092-X. View

2.
Dovc K, Bergford S, Frohlich-Reiterer E, Zaharieva D, Potocnik N, Muller A . A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover Trial. Diabetes Technol Ther. 2023; 25(9):612-621. PMC: 10460686. DOI: 10.1089/dia.2023.0178. View

3.
Reiss A, Jo B, Arbelaez A, Tsalikian E, Buckingham B, Weinzimer S . A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes. Nat Commun. 2022; 13(1):4940. PMC: 9427757. DOI: 10.1038/s41467-022-32289-x. View

4.
Hsu L, Buckingham B, Basina M, Ekhlaspour L, von Eyben R, Wang J . Fast-Acting Insulin Aspart Use with the MiniMed 670G System. Diabetes Technol Ther. 2020; 23(1):1-7. PMC: 7864093. DOI: 10.1089/dia.2020.0083. View

5.
Beck R, Raghinaru D, Calhoun P, Bergenstal R . A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70-180 mg/dL Versus Time-in-Tight-Range 70-140 mg/dL. Diabetes Technol Ther. 2023; 26(3):151-155. DOI: 10.1089/dia.2023.0380. View